Alkermes, Inc.
🏢 View company profile →74Patents
43Active
74Granted
49Portfolio score
Filing activity: Aug 17, 1987 → Nov 22, 2022 · 12 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4902505A | Chimeric peptides for neuropeptide delivery through the blood-brain barrier | Human Necessities | 216 | Expired |
| US5004697A | Cationized antibodies for delivery through the blood-brain barrier | Human Necessities | 214 | Expired |
| US5977307A | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins | Chemistry; Metallurgy | 193 | Expired |
| US5268164A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 177 | Expired |
| US5817343A | Method for fabricating polymer-based controlled-release devices | Human Necessities | 168 | Expired |
| US5672683A | Transferrin neuropharmaceutical agent fusion protein | Chemistry; Metallurgy | 150 | Expired |
| US5506206A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 150 | Expired |
| US5654010A | Composition for sustained release of human growth hormone | Emerging Cross-Sectional Technologies | 148 | Expired |
| US5527527A | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates | Chemistry; Metallurgy | 140 | Expired |
| US5112596A | Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability | Human Necessities | 132 | Expired |
| US5154924A | Transferrin receptor specific antibody-neuropharmaceutical agent conjugates | Chemistry; Metallurgy | 128 | Expired |
| US5667808A | Composition for sustained release of human growth hormone | Emerging Cross-Sectional Technologies | 124 | Expired |
| US5833988A | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates | Chemistry; Metallurgy | 106 | Expired |
| US5182107A | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates | Human Necessities | 105 | Expired |
| US5686416A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 104 | Expired |
| US6015555A | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates | Chemistry; Metallurgy | 101 | Expired |
| US7556798B2 | Highly efficient delivery of a large therapeutic mass aerosol | Human Necessities | 98 | Expired |
| US5674534A | Composition for sustained release of non-aggregated erythropoietin | Emerging Cross-Sectional Technologies | 93 | Expired |
| US5716644A | Composition for sustained release of non-aggregated erythropoietin | Human Necessities | 92 | Expired |
| US7456254B2 | Polymer-based sustained release device | Human Necessities | 69 | Expired |
| US6329508A | Transferrin receptor reactive chimeric antibodies | Chemistry; Metallurgy | 65 | Expired |
| US7563871B2 | Polymer-based sustained release device | Human Necessities | 63 | Active |
| US7612176B2 | Polymer-based sustained release device | Human Necessities | 60 | Active |
| US8338427B2 | Methods for administering aripiprazole | Human Necessities | 29 | Active |
| US7278425B2 | Inhalation device and method | Human Necessities | 28 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.